Clinical trial Recruiting at 1 site Interventional Ages 3 to 7

Oral melatonin versus nebulized dexmedetomidine to reduce emergence agitation after adenotonsillectomy in children

Official title: Comparison Between Oral Melatonin Versus Nebulized Dexmedetomidine on Emergence Agitation in Children Undergoing Adenotonsillectomy: A Prospective, Randomized Controlled Trial

Run by Tanta University · NCT07345715 · Data updated 2026-11-12

We will test whether giving oral melatonin or nebulized dexmedetomidine before anesthesia better prevents children aged 3–7 from becoming agitated as they wake after adenotonsillectomy.

More Asthma in Children trials

Quick facts

Study typeInterventional
Ages3 Years to 7 Years
SexAll
Enrollment96 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, El-Gharbia)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedJuly 1, 2027
Study endsJuly 1, 2027
Registry record updatedJanuary 16, 2026
Trial IDNCT07345715 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3 to 7 years, ASA I–II, scheduled for elective adenotonsillectomy whose parents consent and who do not have the listed neurological, developmental, or medication exclusions are ideal candidates.

Probably not a fit

Children with developmental delays, central nervous system or psychiatric conditions, current or recent anticonvulsant or sedative use, or known hypersensitivity to melatonin, dexmedetomidine, or midazolam are excluded and unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children aged 3–7 with ASA physical status I–II who are scheduled for elective adenotonsillectomy receive a preoperative dose of either oral melatonin, nebulized dexmedetomidine, or normal saline. Emergence agitation and postoperative pain are monitored in the immediate recovery period using standard clinical scales. Patients with developmental delay, central nervous system disorders, recent use of anticonvulsants or sedative medications, or known allergies to the study drugs are excluded. The trial compares the frequency and severity of emergence agitation between the intervention groups to determine which premedication strategy provides better wake-up behavior.

Why it matters

Potential benefit: If successful, the intervention could reduce the frequency and severity of emergence agitation and related postoperative discomfort in young children after adenotonsillectomy.

How similar studies have gone: Previous smaller trials have shown nebulized or intravenous dexmedetomidine can reduce emergence agitation and melatonin has shown promising effects, but direct head-to-head comparisons in this population are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged between 3 and 7 years.
* Both sexes.
* Classified as American Society of Anesthesiologists (ASA) physical status I or II according to the American Society of Anesthesiologists.
* Scheduled for elective adenotonsillectomy under general anesthesia.

Exclusion Criteria:

* Parental refusal to participate in the study.
* Known allergy or hypersensitivity to dexmedetomidine, melatonin or midazolam.
* Presence of developmental delay.
* Central nervous system disorders.
* Intellectual disability (formerly termed mental retardation).
* Neurological or psychiatric conditions associated with anxiety or agitation (e.g., cerebral palsy, epilepsy, separation anxiety disorder, attention-deficit/hyperactivity disorder).
* Current or recent treatment with anticonvulsants or sedative medications

Where it's running

  • Tanta University
    Tanta, El-Gharbia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.